Join NFCR and Dr. Sujuan Ba in Discussion about All Things Cancer
Each episode of All Things Cancer will spotlight the most pressing topics in oncology, from cutting-edge treatments and emerging research to personal stories of resilience and hope. More than just a podcast, it’s a platform for raising awareness, advancing cancer education, and fostering a global community of support and collaboration.
Cancer impacts everyone—whether you’re a patient, caregiver, advocate, or researcher — This podcast delivers invaluable insights from those on the frontlines of the fight against it.
Check Out The Latest Episode of the All Things Cancer Podcast:
Subscribe now to stay up to date on the latest episodes and join the conversation shaping the future of cancer research.
Latest Episodes of All Things Cancer

Episode #12:
Can CAR-T Therapy Finally Conquer Solid Tumors?
In this special conversation, two generations of cancer researchers come together to explore how far we’ve come in cancer treatment—and how bold collaboration is shaping what’s next. Featuring Dr. Brian Leyland-Jones, NFCR’s longtime medical advisor, and Dr. Avery Posey, an NFCR-supported scientist at the University of Pennsylvania.
Listen Now On: Spotify | Apple Podcasts | YouTube

Episode #11:
Rethinking Cancer: A Conversation with Dr. Isaac Witz
In his discussion with NFCR CEO Dr. Sujuan Ba, Dr. Isaac Witz, the 2023 winner of the Szent-Györgyi Prize for Progress in Cancer Research, emphasizes the importance of keeping patients at the heart of research. He explains that therapies cannot simply aim to destroy tumors — they must also consider how the body’s own systems sometimes help cancer survive and spread.
Listen Now On: Spotify | Apple Podcasts | YouTube

Episode #10:
FEATURING: Dr. Drew Pardoll, Johns Hopkins Medicine, Expert in Immunology
Discover how Dr. Drew Pardoll’s pioneering journey in cancer immunology is shaping the future of treatment. In this All Things Cancer episode, he shares the breakthroughs, mentorship, and vision driving progress against cancer.









